Results 191 to 200 of about 282,173 (256)

Special Issue "Molecular Advances in Cancer and Cell Metabolism". [PDF]

Int J Mol Sci
Mesuraca M, Quaresima B, Scicchitano S, Faniello MC.   +3 more
europepmc   +1 more source

Aberrant bcl6 protein expression in patients with EMZL following recurrence or progression: case report of two cases. [PDF]

Diagn Pathol
Zhang M, Qu J, Guo W, Liu Y, Zhang W.
europepmc   +1 more source

MiR-33 as a novel diagnostic biomarker for distinguishing cholesterol from adenomatous polyps: a case-control study. [PDF]

Hereditas
Hu X, Zhang P, Wang T, Li Q, Li M, Zhao Z, Yu R, Tan Y, Yao C.   +8 more
europepmc   +1 more source

Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer. [PDF]

Cancer Res Commun
Schoultz E, Moccia C, Liang S, Johansson E, Nilsson M.   +4 more
europepmc   +1 more source

Association between Parkinson's disease and risk of colorectal cancer: A systematic review and meta‐analysis

Ibrain, EarlyView.
The aim of this study is to examine the association between Parkinson's disease (PD) and colorectal cancer (CRC) risk through a systematic review and meta‐analysis. This study represents the largest meta‐analysis conducted to date on the relationship between CRC risk and PD.
Meng‐Dan Su, Tian‐Hong Wang, Hao‐Wen Zhang, Ke‐Yu Cao, Fei Liu   +4 more
wiley   +1 more source

The endonuclease activity of MCPIP1 controls the neoplastic transformation of epithelial cells via the c-Met/CD44 axis. [PDF]

Cell Commun Signal
Marona P, Myrczek R, Piasecka I, Gorka J, Kwapisz O, Pospiech E, Rys J, Jura J, Miekus K.   +8 more
europepmc   +1 more source

Exploring the Prognostic Value of Tumour-Associated Genes in Clear Cell Renal Cell Carcinoma Through Single-Cell RNA Sequencing Insights. [PDF]

J Cell Mol Med
Fu T, Zhang X, Liu Y, Wu J, Liu X, Lu B, Huang Y, Yang L, Zhan Y.   +8 more
europepmc   +1 more source

Therapeutic targeting of chromatin alterations in leukemia and solid tumors

International Journal of Cancer, EarlyView.
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner, Tobias Berg, Daniel Sasca, Sophie‐Luise Mersiowsky, Jayant Y. Gadrey, Johanna Thomas, Michael W. M. Kühn, Michael Lübbert   +7 more
wiley   +1 more source

TPD52 as a Therapeutic Target Identified by Machine Learning Shapes the Immune Microenvironment in Breast Cancer. [PDF]

J Cell Mol Med
Xia J, Zhou X.
europepmc   +1 more source

Antitumor efficacy of intermittent low‐dose erlotinib plus sulindac via MHC upregulation and remodeling of the immune cell niche

International Journal of Cancer, EarlyView.
What's New? Novel immunomodulatory insights derived from experimental models and clinical samples reveal the cancer‐preventive potential of intermittent low‐dose erlotinib plus sulindac (ERL + SUL). This study shows that ERL + SUL treatment upregulates MHC class I and II expression and remodels the immune cell niche, with significant tumor suppression ...
Chakrapani Tripathi, Jorge E. Tovar Perez, Sabeeta Kapoor, Ahmed Muhsin, Wan Mohaiza Dashwood, Yunus Demirhan, Melek Demirhan, Alessandro Shapiro, Altaf Mohammed, Shizuko Sei, Jacklyn Thompson, Mahira Zaheer, Krishna M. Sinha, Powel H. Brown, Michelle I. Savage, Eduardo Vilar, Praveen Rajendran, Roderick H. Dashwood   +17 more
wiley   +1 more source